A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.

Summary

Bioequivalence study is proposed to be carried out on patients of ovarian cancer, who are already receiving or who in the opinion of their treating physicians are candidates for Doxorubicin liposomal injection therapy .

Timeline

Start

2018-08-29

Primary completion

2019-02-08

Completion

2019-03-07

Drugs

Indications